Literature DB >> 6253315

Solution spatial structure of apamin as derived from NMR study.

V F Bystrov, V V Okhanov, A I Miroshnikov, Y A Ovchinnikov.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6253315     DOI： 10.1016/0014-5793(80)81010-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  7 in total

1.  Solution structure of hpTX2, a toxin from Heteropoda venatoria spider that blocks Kv4.2 potassium channel.

Authors:  C Bernard; C Legros; G Ferrat; U Bischoff; A Marquardt; O Pongs; H Darbon
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

Review 2.  Potassium channels--multiplicity and challenges.

Authors:  Donald H Jenkinson
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 3.  Use of toxins to study potassium channels.

Authors:  M L Garcia; A Galvez; M Garcia-Calvo; V F King; J Vazquez; G J Kaczorowski
Journal:  J Bioenerg Biomembr       Date:  1991-08       Impact factor: 2.945

4.  The disulfide-coupled folding pathway of apamin as derived from diselenide-quenched analogs and intermediates.

Authors:  S Pegoraro; S Fiori; J Cramer; S Rudolph-Böhner; L Moroder
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

Review 5.  An emerging pharmacology of peptide toxins targeted against potassium channels.

Authors:  E Moczydlowski; K Lucchesi; A Ravindran
Journal:  J Membr Biol       Date:  1988-10       Impact factor: 1.843

Review 6.  Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor.

Authors:  Victor J Hruby; Minying Cai; James P Cain; Alexander V Mayorov; Matthew M Dedek; Devendra Trivedi
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

7.  Apamin structure and pharmacology revisited.

Authors:  Alexey I Kuzmenkov; Steve Peigneur; Joshua A Nasburg; Konstantin S Mineev; Maxim V Nikolaev; Ernesto Lopes Pinheiro-Junior; Alexander S Arseniev; Heike Wulff; Jan Tytgat; Alexander A Vassilevski
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.